These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

525 related items for PubMed ID: 16170353

  • 21. MS-275, a novel histone deacetylase inhibitor with selectivity against HDAC1, induces degradation of FLT3 via inhibition of chaperone function of heat shock protein 90 in AML cells.
    Nishioka C, Ikezoe T, Yang J, Takeuchi S, Koeffler HP, Yokoyama A.
    Leuk Res; 2008 Sep; 32(9):1382-92. PubMed ID: 18394702
    [Abstract] [Full Text] [Related]

  • 22. Regulation of vascular endothelial growth factor expression by EMMPRIN via the PI3K-Akt signaling pathway.
    Tang Y, Nakada MT, Rafferty P, Laraio J, McCabe FL, Millar H, Cunningham M, Snyder LA, Bugelski P, Yan L.
    Mol Cancer Res; 2006 Jun; 4(6):371-7. PubMed ID: 16778084
    [Abstract] [Full Text] [Related]

  • 23. Epidermal growth factor stimulates urokinase-type plasminogen activator expression in human gingival fibroblasts. Possible modulation by genistein and curcumin.
    Smith PC, Santibañez JF, Morales JP, Martinez J.
    J Periodontal Res; 2004 Dec; 39(6):380-7. PubMed ID: 15491342
    [Abstract] [Full Text] [Related]

  • 24. Breast tumor kinase (protein tyrosine kinase 6) regulates heregulin-induced activation of ERK5 and p38 MAP kinases in breast cancer cells.
    Ostrander JH, Daniel AR, Lofgren K, Kleer CG, Lange CA.
    Cancer Res; 2007 May 01; 67(9):4199-209. PubMed ID: 17483331
    [Abstract] [Full Text] [Related]

  • 25. Amyloid beta peptide-activated signal pathways in human platelets.
    Shen MY, Hsiao G, Fong TH, Chen HM, Chou DS, Lin CH, Sheu JR, Hsu CY.
    Eur J Pharmacol; 2008 Jul 07; 588(2-3):259-66. PubMed ID: 18511035
    [Abstract] [Full Text] [Related]

  • 26. Co-targeting the EGFR and IGF-IR with anti-EGFR monoclonal antibody ICR62 and the IGF-IR tyrosine kinase inhibitor NVP-AEW541 in colorectal cancer cells.
    Cunningham MP, Thomas H, Marks C, Green M, Fan Z, Modjtahedi H.
    Int J Oncol; 2008 Nov 07; 33(5):1107-13. PubMed ID: 18949375
    [Abstract] [Full Text] [Related]

  • 27. In vitro and in vivo antitumor effects of the dual insulin-like growth factor-I/insulin receptor inhibitor, BMS-554417.
    Haluska P, Carboni JM, Loegering DA, Lee FY, Wittman M, Saulnier MG, Frennesson DB, Kalli KR, Conover CA, Attar RM, Kaufmann SH, Gottardis M, Erlichman C.
    Cancer Res; 2006 Jan 01; 66(1):362-71. PubMed ID: 16397250
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Recombinant human insulin-like growth factor binding protein 3 inhibits growth of human epidermal growth factor receptor-2-overexpressing breast tumors and potentiates herceptin activity in vivo.
    Jerome L, Alami N, Belanger S, Page V, Yu Q, Paterson J, Shiry L, Pegram M, Leyland-Jones B.
    Cancer Res; 2006 Jul 15; 66(14):7245-52. PubMed ID: 16849573
    [Abstract] [Full Text] [Related]

  • 30. Pleiotropic effects of the sirtuin inhibitor sirtinol involves concentration-dependent modulation of multiple nuclear receptor-mediated pathways in androgen-responsive prostate cancer cell LNCaP.
    Wang TT, Schoene NW, Kim EK, Kim YS.
    Mol Carcinog; 2013 Sep 15; 52(9):676-85. PubMed ID: 22495798
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. NO donor and MEK inhibitor synergistically inhibit proliferation and invasion of cancer cells.
    Furuhashi S, Sugita H, Takamori H, Horino K, Nakahara O, Okabe H, Miyake K, Tanaka H, Beppu T, Baba H.
    Int J Oncol; 2012 Mar 15; 40(3):807-15. PubMed ID: 22025280
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. MS-275, a histone deacetylase inhibitor, selectively induces transforming growth factor beta type II receptor expression in human breast cancer cells.
    Lee BI, Park SH, Kim JW, Sausville EA, Kim HT, Nakanishi O, Trepel JB, Kim SJ.
    Cancer Res; 2001 Feb 01; 61(3):931-4. PubMed ID: 11221885
    [Abstract] [Full Text] [Related]

  • 35. Inhibition of epidermal growth factor-induced cell transformation by tannins.
    Nomura M, Tsukada H, Ichimatsu D, Ito H, Yoshida T, Miyamoto K.
    Phytochemistry; 2005 Sep 01; 66(17):2038-46. PubMed ID: 16153407
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. SIRT1 promotes proliferation and prevents senescence through targeting LKB1 in primary porcine aortic endothelial cells.
    Zu Y, Liu L, Lee MY, Xu C, Liang Y, Man RY, Vanhoutte PM, Wang Y.
    Circ Res; 2010 Apr 30; 106(8):1384-93. PubMed ID: 20203304
    [Abstract] [Full Text] [Related]

  • 38. Insulin-like growth factor 1 prevents neuronal cell death induced by corticosterone through activation of the PI3k/Akt pathway.
    Nitta A, Zheng WH, Quirion R.
    J Neurosci Res; 2004 Apr 01; 76(1):98-103. PubMed ID: 15048933
    [Abstract] [Full Text] [Related]

  • 39. Protein kinase A-Ialpha subunit-directed antisense inhibition of ovarian cancer cell growth: crosstalk with tyrosine kinase signaling pathway.
    Alper O, Hacker NF, Cho-Chung YS.
    Oncogene; 1999 Sep 02; 18(35):4999-5004. PubMed ID: 10490835
    [Abstract] [Full Text] [Related]

  • 40. Benzo(a)pyrene quinones increase cell proliferation, generate reactive oxygen species, and transactivate the epidermal growth factor receptor in breast epithelial cells.
    Burdick AD, Davis JW, Liu KJ, Hudson LG, Shi H, Monske ML, Burchiel SW.
    Cancer Res; 2003 Nov 15; 63(22):7825-33. PubMed ID: 14633709
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 27.